Werewolf Therapeutics, Inc. — Investor Relations & Filings
Werewolf Therapeutics, Inc. is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company utilizes its proprietary PREDATOR® protein engineering platform to create a novel class of conditionally activated proinflammatory immune modulators, known as INDUKINE™ and INDUCER™ molecules. These therapies are designed to be delivered systemically in an inactive state and become selectively activated within the tumor microenvironment. This approach aims to generate a potent, localized anti-tumor immune response while minimizing the systemic side effects associated with conventional immunotherapies. The company's pipeline includes clinical-stage candidates such as WTX-124 and WTX-330.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2025 | 2025-12-22 | English | |
| Regulatory Filings 2025 | 2025-12-22 | English | |
| 8-K | 2025-12-18 | English | |
| Director's Dealing 2025 | 2025-12-18 | English | |
| Director's Dealing 2025 | 2025-12-12 | English | |
| Regulatory Filings 2025 | 2025-12-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 13198071 | Regulatory Filings 2025 | 2025-12-22 | English | ||
| 13198072 | Regulatory Filings 2025 | 2025-12-22 | English | ||
| 13198074 | 8-K | 2025-12-18 | English | ||
| 13198075 | Director's Dealing 2025 | 2025-12-18 | English | ||
| 13198076 | Director's Dealing 2025 | 2025-12-12 | English | ||
| 13198077 | Regulatory Filings 2025 | 2025-12-10 | English | ||
| 13198078 | Regulatory Filings 2025 | 2025-12-10 | English | ||
| 13198079 | Regulatory Filings 2025 | 2025-12-10 | English | ||
| 13198080 | Regulatory Filings 2025 | 2025-12-10 | English | ||
| 13198081 | Regulatory Filings 2025 | 2025-12-10 | English | ||
| 13198082 | Regulatory Filings 2025 | 2025-12-10 | English | ||
| 13198083 | Director's Dealing 2025 | 2025-12-09 | English | ||
| 13198084 | Director's Dealing 2025 | 2025-12-05 | English | ||
| 13198085 | Director's Dealing 2025 | 2025-12-05 | English | ||
| 13198086 | Director's Dealing 2025 | 2025-12-05 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Werewolf Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34192/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34192 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34192 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34192 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34192}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Werewolf Therapeutics, Inc. (id: 34192)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.